Index by author

November 01 1999; volume 22 issue 11

A

  1. Abraham, M R

    1. Lispro in the treatment of insulin allergy.
      M R Abraham, B A al-Sharafi, G A Saavedra and R Khardori
      Diabetes Care 1999 Nov; 22 (11): 1916-1917. https://doi.org/10.2337/diacare.22.11.1916

  2. Ahrén, B

    1. The relationship between leptin and the insulin resistance syndrome is disturbed in type 2 diabetic subjects with parasympathetic neuropathy.
      A Gottsäter, B Ahrén and G Sundkvist
      Diabetes Care 1999 Nov; 22 (11): 1913-1914. https://doi.org/10.2337/diacare.22.11.1913

  3. al-Sharafi, B A

    1. Lispro in the treatment of insulin allergy.
      M R Abraham, B A al-Sharafi, G A Saavedra and R Khardori
      Diabetes Care 1999 Nov; 22 (11): 1916-1917. https://doi.org/10.2337/diacare.22.11.1916

  4. Alexander, C M

    1. Effect of simvastatin treatment on cardiovascular resource utilization in impaired fasting glucose and diabetes. Findings from the Scandinavian Simvastatin Survival Study.
      W H Herman, C M Alexander, J R Cook, S J Boccuzzi, T A Musliner, T R Pedersen, J Kjekshus and K Pyörälä
      Diabetes Care 1999 Nov; 22 (11): 1771-1778. https://doi.org/10.2337/diacare.22.11.1771

B

  1. Bergstrom, R W

    1. Visceral adiposity and incident coronary heart disease in Japanese-American men. The 10-year follow-up results of the Seattle Japanese-American Community Diabetes Study.
      W Y Fujimoto, R W Bergstrom, E J Boyko, K W Chen, D L Leonetti, L Newell-Morris, J B Shofer and P W Wahl
      Diabetes Care 1999 Nov; 22 (11): 1808-1812. https://doi.org/10.2337/diacare.22.11.1808

  2. Berntorp, K

    1. Obesity, microalbuminuria, hyperinsulinemia, and increased plasminogen activator inhibitor 1 activity associated with parasympathetic neuropathy in type 2 diabetes.
      B Szelag, M Wroblewski, J Castenfors, M Henricsson, K Berntorp, P Fernlund and G Sundkvist
      Diabetes Care 1999 Nov; 22 (11): 1907-1908. https://doi.org/10.2337/diacare.22.11.1907

  3. Bingley, P J

    1. Optimized autoantibody-based risk assessment in family members. Implications for future intervention trials.
      P J Bingley, A J Williams and E A Gale
      Diabetes Care 1999 Nov; 22 (11): 1796-1801. https://doi.org/10.2337/diacare.22.11.1796

  4. Bjørndal, A

    1. Rapid changes in the prevalence of obesity and known diabetes in an adult Norwegian population. The Nord-Trøndelag Health Surveys: 1984-1986 and 1995-1997.
      K Midthjell, O Krüger, J Holmen, A Tverdal, T Claudi, A Bjørndal and P Magnus
      Diabetes Care 1999 Nov; 22 (11): 1813-1820. https://doi.org/10.2337/diacare.22.11.1813

  5. Bloomgarden, Z T

    1. American Diabetes Association Annual Meeting, 1999. New approaches to type 1 diabetes.
      Z T Bloomgarden
      Diabetes Care 1999 Nov; 22 (11): 1899-1903. https://doi.org/10.2337/diacare.22.11.1899

  6. Boccuzzi, S J

    1. Effect of simvastatin treatment on cardiovascular resource utilization in impaired fasting glucose and diabetes. Findings from the Scandinavian Simvastatin Survival Study.
      W H Herman, C M Alexander, J R Cook, S J Boccuzzi, T A Musliner, T R Pedersen, J Kjekshus and K Pyörälä
      Diabetes Care 1999 Nov; 22 (11): 1771-1778. https://doi.org/10.2337/diacare.22.11.1771

  7. Boer, J M

    1. Diabetes prevalence in offspring of elderly men with known and newly diagnosed diabetes.
      E J Feskens, J M Boer, R M van Dam, M J Ritsema and D Kromhout
      Diabetes Care 1999 Nov; 22 (11): 1919. https://doi.org/10.2337/diacare.22.11.1919b

  8. Boland, E A

    1. Continuous subcutaneous insulin infusion. A new way to lower risk of severe hypoglycemia, improve metabolic control, and enhance coping in adolescents with type 1 diabetes.
      E A Boland, M Grey, A Oesterle, L Fredrickson and W V Tamborlane
      Diabetes Care 1999 Nov; 22 (11): 1779-1784. https://doi.org/10.2337/diacare.22.11.1779

  9. Boulton, A J

    1. Specific fiber deficits in sensorimotor diabetic polyneuropathy correspond to cytotoxicity against neuroblastoma cells of sera from patients with diabetes.
      G L Pittenger, R A Malik, N Burcus, A J Boulton and A I Vinik
      Diabetes Care 1999 Nov; 22 (11): 1839-1844. https://doi.org/10.2337/diacare.22.11.1839

  10. Bourguignon, J P

    1. Cardiac autonomic dysfunction in diabetic children.
      M M Massin, B Derkenne, M Tallsund, D Rocour-Brumioul, C Ernould, M C Lebrethon and J P Bourguignon
      Diabetes Care 1999 Nov; 22 (11): 1845-1850. https://doi.org/10.2337/diacare.22.11.1845

  11. Boyko, E J

    1. Visceral adiposity and incident coronary heart disease in Japanese-American men. The 10-year follow-up results of the Seattle Japanese-American Community Diabetes Study.
      W Y Fujimoto, R W Bergstrom, E J Boyko, K W Chen, D L Leonetti, L Newell-Morris, J B Shofer and P W Wahl
      Diabetes Care 1999 Nov; 22 (11): 1808-1812. https://doi.org/10.2337/diacare.22.11.1808

  12. Bretzel, R

    1. Type 2 diabetes and acute myocardial infarction. Angiographic findings and results of an invasive therapeutic approach in type 2 diabetic versus nondiabetic patients.
      B Waldecker, W Waas, W Haberbosch, R Voss, M K Steen-Müller, A Hiddessen, R Bretzel and H Tillmanns
      Diabetes Care 1999 Nov; 22 (11): 1832-1838. https://doi.org/10.2337/diacare.22.11.1832

  13. Burcus, N

    1. Specific fiber deficits in sensorimotor diabetic polyneuropathy correspond to cytotoxicity against neuroblastoma cells of sera from patients with diabetes.
      G L Pittenger, R A Malik, N Burcus, A J Boulton and A I Vinik
      Diabetes Care 1999 Nov; 22 (11): 1839-1844. https://doi.org/10.2337/diacare.22.11.1839

C

  1. Caballero, A E

    1. Soluble intercellular adhesion molecule, vascular cell adhesion molecule, and impaired microvascular reactivity are early markers of vasculopathy in type 2 diabetic individuals without microalbuminuria.
      S C Lim, A E Caballero, P Smakowski, F W LoGerfo, E S Horton and A Veves
      Diabetes Care 1999 Nov; 22 (11): 1865-1870. https://doi.org/10.2337/diacare.22.11.1865

  2. Cacciatori, V

    1. Chronic cigarette smoking is associated with increased plasma circulating intercellular adhesion molecule 1 levels in young type 1 diabetic patients.
      G Zoppini, G Targher, V Cacciatori, A Guerriero and M Muggeo
      Diabetes Care 1999 Nov; 22 (11): 1871-1874. https://doi.org/10.2337/diacare.22.11.1871

  3. Cagliero, E

    1. Immediate feedback of HbA1c levels improves glycemic control in type 1 and insulin-treated type 2 diabetic patients.
      E Cagliero, E V Levina and D M Nathan
      Diabetes Care 1999 Nov; 22 (11): 1785-1789. https://doi.org/10.2337/diacare.22.11.1785

  4. Campistol, J M

    1. Smoking increases serum levels of transforming growth factor-beta in diabetic patients.
      E Esmatjes, L Flores, S Lario, J Clària, A Cases, P Iñigo and J M Campistol
      Diabetes Care 1999 Nov; 22 (11): 1915-1916. https://doi.org/10.2337/diacare.22.11.1915

  5. Cases, A

    1. Smoking increases serum levels of transforming growth factor-beta in diabetic patients.
      E Esmatjes, L Flores, S Lario, J Clària, A Cases, P Iñigo and J M Campistol
      Diabetes Care 1999 Nov; 22 (11): 1915-1916. https://doi.org/10.2337/diacare.22.11.1915

  6. Castenfors, J

    1. Obesity, microalbuminuria, hyperinsulinemia, and increased plasminogen activator inhibitor 1 activity associated with parasympathetic neuropathy in type 2 diabetes.
      B Szelag, M Wroblewski, J Castenfors, M Henricsson, K Berntorp, P Fernlund and G Sundkvist
      Diabetes Care 1999 Nov; 22 (11): 1907-1908. https://doi.org/10.2337/diacare.22.11.1907

  7. Cervantes Aguayo, F C

    1. Diabetic retinopathy and risk of blindness in Mexico. Are we doing enough?
      E Rodríguez Villalobos, E J Ramíez Barba, F C Cervantes Aguayo and E Vargas Salado
      Diabetes Care 1999 Nov; 22 (11): 1905. https://doi.org/10.2337/diacare.22.11.1905

  8. Chan, J C

    1. Use of a paired value of fasting plasma glucose and glycated hemoglobin in predicting the likelihood of diabetes in a community.
      G T Ko, J C Chan and C S Cockram
      Diabetes Care 1999 Nov; 22 (11): 1908-1909. https://doi.org/10.2337/diacare.22.11.1908

  9. Chen, K W

    1. Visceral adiposity and incident coronary heart disease in Japanese-American men. The 10-year follow-up results of the Seattle Japanese-American Community Diabetes Study.
      W Y Fujimoto, R W Bergstrom, E J Boyko, K W Chen, D L Leonetti, L Newell-Morris, J B Shofer and P W Wahl
      Diabetes Care 1999 Nov; 22 (11): 1808-1812. https://doi.org/10.2337/diacare.22.11.1808

  10. Clària, J

    1. Smoking increases serum levels of transforming growth factor-beta in diabetic patients.
      E Esmatjes, L Flores, S Lario, J Clària, A Cases, P Iñigo and J M Campistol
      Diabetes Care 1999 Nov; 22 (11): 1915-1916. https://doi.org/10.2337/diacare.22.11.1915

  11. Claudi, T

    1. Rapid changes in the prevalence of obesity and known diabetes in an adult Norwegian population. The Nord-Trøndelag Health Surveys: 1984-1986 and 1995-1997.
      K Midthjell, O Krüger, J Holmen, A Tverdal, T Claudi, A Bjørndal and P Magnus
      Diabetes Care 1999 Nov; 22 (11): 1813-1820. https://doi.org/10.2337/diacare.22.11.1813

  12. Cockram, C S

    1. Use of a paired value of fasting plasma glucose and glycated hemoglobin in predicting the likelihood of diabetes in a community.
      G T Ko, J C Chan and C S Cockram
      Diabetes Care 1999 Nov; 22 (11): 1908-1909. https://doi.org/10.2337/diacare.22.11.1908

  13. Cook, J R

    1. Effect of simvastatin treatment on cardiovascular resource utilization in impaired fasting glucose and diabetes. Findings from the Scandinavian Simvastatin Survival Study.
      W H Herman, C M Alexander, J R Cook, S J Boccuzzi, T A Musliner, T R Pedersen, J Kjekshus and K Pyörälä
      Diabetes Care 1999 Nov; 22 (11): 1771-1778. https://doi.org/10.2337/diacare.22.11.1771

D

  1. Davis, J L

    1. Painful peripheral diabetic neuropathy treated with venlafaxine HCl extended release capsules.
      J L Davis and R L Smith
      Diabetes Care 1999 Nov; 22 (11): 1909-1910. https://doi.org/10.2337/diacare.22.11.1909

  2. Dellon, A L

    1. Insulin resistance. Does it play a role in peripheral neuropathy?
      R H Lee and A L Dellon
      Diabetes Care 1999 Nov; 22 (11): 1914-1915. https://doi.org/10.2337/diacare.22.11.1914

  3. Derkenne, B

    1. Cardiac autonomic dysfunction in diabetic children.
      M M Massin, B Derkenne, M Tallsund, D Rocour-Brumioul, C Ernould, M C Lebrethon and J P Bourguignon
      Diabetes Care 1999 Nov; 22 (11): 1845-1850. https://doi.org/10.2337/diacare.22.11.1845

  4. Doi, K

    1. Homeostasis model assessment as a clinical index of insulin resistance. Comparison with the minimal model analysis.
      M Fukushima, A Taniguchi, M Sakai, K Doi, S Nagasaka, H Tanaka, K Tokuyama and Y Nakai
      Diabetes Care 1999 Nov; 22 (11): 1911-1912. https://doi.org/10.2337/diacare.22.11.1911

  5. Dost, A

    1. Physical activity and competitive sports in children and adolescents with type 1 diabetes.
      K Raile, T Kapellen, A Schweiger, F Hunkert, U Nietzschmann, A Dost and W Kiess
      Diabetes Care 1999 Nov; 22 (11): 1904-1905. https://doi.org/10.2337/diacare.22.11.1904

E

  1. Emoto, M

    1. Correlation between the intima-media thickness of the carotid artery and aortic pulse-wave velocity in patients with type 2 diabetes. Vessel wall properties in type 2 diabetes.
      H Taniwaki, T Kawagishi, M Emoto, T Shoji, H Kanda, K Maekawa, Y Nishizawa and H Morii
      Diabetes Care 1999 Nov; 22 (11): 1851-1857. https://doi.org/10.2337/diacare.22.11.1851
    2. Association of ACE gene polymorphism with arterial stiffness in patients with type 2 diabetes.
      H Taniwaki, T Kawagishi, M Emoto, T Shoji, M Hosoi, K Kogawa, Y Nishizawa and H Morii
      Diabetes Care 1999 Nov; 22 (11): 1858-1864. https://doi.org/10.2337/diacare.22.11.1858

  2. Ernould, C

    1. Cardiac autonomic dysfunction in diabetic children.
      M M Massin, B Derkenne, M Tallsund, D Rocour-Brumioul, C Ernould, M C Lebrethon and J P Bourguignon
      Diabetes Care 1999 Nov; 22 (11): 1845-1850. https://doi.org/10.2337/diacare.22.11.1845

  3. Esmatjes, E

    1. Smoking increases serum levels of transforming growth factor-beta in diabetic patients.
      E Esmatjes, L Flores, S Lario, J Clària, A Cases, P Iñigo and J M Campistol
      Diabetes Care 1999 Nov; 22 (11): 1915-1916. https://doi.org/10.2337/diacare.22.11.1915

F

  1. Fernlund, P

    1. Obesity, microalbuminuria, hyperinsulinemia, and increased plasminogen activator inhibitor 1 activity associated with parasympathetic neuropathy in type 2 diabetes.
      B Szelag, M Wroblewski, J Castenfors, M Henricsson, K Berntorp, P Fernlund and G Sundkvist
      Diabetes Care 1999 Nov; 22 (11): 1907-1908. https://doi.org/10.2337/diacare.22.11.1907

  2. Feskens, E J

    1. Diabetes prevalence in offspring of elderly men with known and newly diagnosed diabetes.
      E J Feskens, J M Boer, R M van Dam, M J Ritsema and D Kromhout
      Diabetes Care 1999 Nov; 22 (11): 1919. https://doi.org/10.2337/diacare.22.11.1919b

  3. Flores, L

    1. Smoking increases serum levels of transforming growth factor-beta in diabetic patients.
      E Esmatjes, L Flores, S Lario, J Clària, A Cases, P Iñigo and J M Campistol
      Diabetes Care 1999 Nov; 22 (11): 1915-1916. https://doi.org/10.2337/diacare.22.11.1915

  4. Fredrickson, L

    1. Continuous subcutaneous insulin infusion. A new way to lower risk of severe hypoglycemia, improve metabolic control, and enhance coping in adolescents with type 1 diabetes.
      E A Boland, M Grey, A Oesterle, L Fredrickson and W V Tamborlane
      Diabetes Care 1999 Nov; 22 (11): 1779-1784. https://doi.org/10.2337/diacare.22.11.1779

  5. Fujimoto, W Y

    1. Visceral adiposity and incident coronary heart disease in Japanese-American men. The 10-year follow-up results of the Seattle Japanese-American Community Diabetes Study.
      W Y Fujimoto, R W Bergstrom, E J Boyko, K W Chen, D L Leonetti, L Newell-Morris, J B Shofer and P W Wahl
      Diabetes Care 1999 Nov; 22 (11): 1808-1812. https://doi.org/10.2337/diacare.22.11.1808

  6. Fukushima, M

    1. Homeostasis model assessment as a clinical index of insulin resistance. Comparison with the minimal model analysis.
      M Fukushima, A Taniguchi, M Sakai, K Doi, S Nagasaka, H Tanaka, K Tokuyama and Y Nakai
      Diabetes Care 1999 Nov; 22 (11): 1911-1912. https://doi.org/10.2337/diacare.22.11.1911

G

  1. Gale, E A

    1. Optimized autoantibody-based risk assessment in family members. Implications for future intervention trials.
      P J Bingley, A J Williams and E A Gale
      Diabetes Care 1999 Nov; 22 (11): 1796-1801. https://doi.org/10.2337/diacare.22.11.1796

  2. Gappmayer, B

    1. Prospective evaluation of urinary N-acetyl-beta-D-glucosaminidase with respect to macrovascular disease in elderly type 2 diabetic patients.
      R Weitgasser, F Schnoell, B Gappmayer and I Kartnig
      Diabetes Care 1999 Nov; 22 (11): 1882-1886. https://doi.org/10.2337/diacare.22.11.1882

  3. Glasgow, R E

    1. Smoking and diabetes.
      D Haire-Joshu, R E Glasgow and T L Tibbs
      Diabetes Care 1999 Nov; 22 (11): 1887-1898. https://doi.org/10.2337/diacare.22.11.1887

  4. Gottsäter, A

    1. The relationship between leptin and the insulin resistance syndrome is disturbed in type 2 diabetic subjects with parasympathetic neuropathy.
      A Gottsäter, B Ahrén and G Sundkvist
      Diabetes Care 1999 Nov; 22 (11): 1913-1914. https://doi.org/10.2337/diacare.22.11.1913

  5. Grey, M

    1. Continuous subcutaneous insulin infusion. A new way to lower risk of severe hypoglycemia, improve metabolic control, and enhance coping in adolescents with type 1 diabetes.
      E A Boland, M Grey, A Oesterle, L Fredrickson and W V Tamborlane
      Diabetes Care 1999 Nov; 22 (11): 1779-1784. https://doi.org/10.2337/diacare.22.11.1779

  6. Guerriero, A

    1. Chronic cigarette smoking is associated with increased plasma circulating intercellular adhesion molecule 1 levels in young type 1 diabetic patients.
      G Zoppini, G Targher, V Cacciatori, A Guerriero and M Muggeo
      Diabetes Care 1999 Nov; 22 (11): 1871-1874. https://doi.org/10.2337/diacare.22.11.1871

H

  1. Haberbosch, W

    1. Type 2 diabetes and acute myocardial infarction. Angiographic findings and results of an invasive therapeutic approach in type 2 diabetic versus nondiabetic patients.
      B Waldecker, W Waas, W Haberbosch, R Voss, M K Steen-Müller, A Hiddessen, R Bretzel and H Tillmanns
      Diabetes Care 1999 Nov; 22 (11): 1832-1838. https://doi.org/10.2337/diacare.22.11.1832

  2. Haire-Joshu, D

    1. Smoking and diabetes.
      D Haire-Joshu, R E Glasgow and T L Tibbs
      Diabetes Care 1999 Nov; 22 (11): 1887-1898. https://doi.org/10.2337/diacare.22.11.1887

  3. Henderson, J A

    1. Glycemic control in diabetic American Indians. Longitudinal data from the Strong Heart Study.
      D Hu, J A Henderson, T K Welty, E T Lee, K A Jablonski, M F Magee, D C Robbins and B V Howard
      Diabetes Care 1999 Nov; 22 (11): 1802-1807. https://doi.org/10.2337/diacare.22.11.1802

  4. Henricsson, M

    1. Obesity, microalbuminuria, hyperinsulinemia, and increased plasminogen activator inhibitor 1 activity associated with parasympathetic neuropathy in type 2 diabetes.
      B Szelag, M Wroblewski, J Castenfors, M Henricsson, K Berntorp, P Fernlund and G Sundkvist
      Diabetes Care 1999 Nov; 22 (11): 1907-1908. https://doi.org/10.2337/diacare.22.11.1907

  5. Herman, W H

    1. Effect of simvastatin treatment on cardiovascular resource utilization in impaired fasting glucose and diabetes. Findings from the Scandinavian Simvastatin Survival Study.
      W H Herman, C M Alexander, J R Cook, S J Boccuzzi, T A Musliner, T R Pedersen, J Kjekshus and K Pyörälä
      Diabetes Care 1999 Nov; 22 (11): 1771-1778. https://doi.org/10.2337/diacare.22.11.1771

  6. Hiddessen, A

    1. Type 2 diabetes and acute myocardial infarction. Angiographic findings and results of an invasive therapeutic approach in type 2 diabetic versus nondiabetic patients.
      B Waldecker, W Waas, W Haberbosch, R Voss, M K Steen-Müller, A Hiddessen, R Bretzel and H Tillmanns
      Diabetes Care 1999 Nov; 22 (11): 1832-1838. https://doi.org/10.2337/diacare.22.11.1832

  7. Holmen, J

    1. Rapid changes in the prevalence of obesity and known diabetes in an adult Norwegian population. The Nord-Trøndelag Health Surveys: 1984-1986 and 1995-1997.
      K Midthjell, O Krüger, J Holmen, A Tverdal, T Claudi, A Bjørndal and P Magnus
      Diabetes Care 1999 Nov; 22 (11): 1813-1820. https://doi.org/10.2337/diacare.22.11.1813

  8. Horton, E S

    1. Soluble intercellular adhesion molecule, vascular cell adhesion molecule, and impaired microvascular reactivity are early markers of vasculopathy in type 2 diabetic individuals without microalbuminuria.
      S C Lim, A E Caballero, P Smakowski, F W LoGerfo, E S Horton and A Veves
      Diabetes Care 1999 Nov; 22 (11): 1865-1870. https://doi.org/10.2337/diacare.22.11.1865

  9. Hosoi, M

    1. Association of ACE gene polymorphism with arterial stiffness in patients with type 2 diabetes.
      H Taniwaki, T Kawagishi, M Emoto, T Shoji, M Hosoi, K Kogawa, Y Nishizawa and H Morii
      Diabetes Care 1999 Nov; 22 (11): 1858-1864. https://doi.org/10.2337/diacare.22.11.1858

  10. Howard, B V

    1. Glycemic control in diabetic American Indians. Longitudinal data from the Strong Heart Study.
      D Hu, J A Henderson, T K Welty, E T Lee, K A Jablonski, M F Magee, D C Robbins and B V Howard
      Diabetes Care 1999 Nov; 22 (11): 1802-1807. https://doi.org/10.2337/diacare.22.11.1802

  11. Hu, D

    1. Glycemic control in diabetic American Indians. Longitudinal data from the Strong Heart Study.
      D Hu, J A Henderson, T K Welty, E T Lee, K A Jablonski, M F Magee, D C Robbins and B V Howard
      Diabetes Care 1999 Nov; 22 (11): 1802-1807. https://doi.org/10.2337/diacare.22.11.1802

  12. Hunkert, F

    1. Physical activity and competitive sports in children and adolescents with type 1 diabetes.
      K Raile, T Kapellen, A Schweiger, F Hunkert, U Nietzschmann, A Dost and W Kiess
      Diabetes Care 1999 Nov; 22 (11): 1904-1905. https://doi.org/10.2337/diacare.22.11.1904

I

  1. Ikeda, Y

    1. Fasting serum insulin concentrations are associated with QTc duration independent of serum leptin, percent body fat, and BMI.
      T Kazumi, A Kawaguchi, J Katoh, Y Ikeda, K Kishi and G Yoshino
      Diabetes Care 1999 Nov; 22 (11): 1917-1918. https://doi.org/10.2337/diacare.22.11.1917

  2. Iñigo, P

    1. Smoking increases serum levels of transforming growth factor-beta in diabetic patients.
      E Esmatjes, L Flores, S Lario, J Clària, A Cases, P Iñigo and J M Campistol
      Diabetes Care 1999 Nov; 22 (11): 1915-1916. https://doi.org/10.2337/diacare.22.11.1915

J

  1. Jablonski, K A

    1. Glycemic control in diabetic American Indians. Longitudinal data from the Strong Heart Study.
      D Hu, J A Henderson, T K Welty, E T Lee, K A Jablonski, M F Magee, D C Robbins and B V Howard
      Diabetes Care 1999 Nov; 22 (11): 1802-1807. https://doi.org/10.2337/diacare.22.11.1802
    2. Effect of physician specialty on outcomes in diabetic ketoacidosis.
      C S Levetan, M D Passaro, K A Jablonski and R E Ratner
      Diabetes Care 1999 Nov; 22 (11): 1790-1795. https://doi.org/10.2337/diacare.22.11.1790

K

  1. Kanda, H

    1. Correlation between the intima-media thickness of the carotid artery and aortic pulse-wave velocity in patients with type 2 diabetes. Vessel wall properties in type 2 diabetes.
      H Taniwaki, T Kawagishi, M Emoto, T Shoji, H Kanda, K Maekawa, Y Nishizawa and H Morii
      Diabetes Care 1999 Nov; 22 (11): 1851-1857. https://doi.org/10.2337/diacare.22.11.1851

  2. Kapellen, T

    1. Physical activity and competitive sports in children and adolescents with type 1 diabetes.
      K Raile, T Kapellen, A Schweiger, F Hunkert, U Nietzschmann, A Dost and W Kiess
      Diabetes Care 1999 Nov; 22 (11): 1904-1905. https://doi.org/10.2337/diacare.22.11.1904

  3. Kartnig, I

    1. Prospective evaluation of urinary N-acetyl-beta-D-glucosaminidase with respect to macrovascular disease in elderly type 2 diabetic patients.
      R Weitgasser, F Schnoell, B Gappmayer and I Kartnig
      Diabetes Care 1999 Nov; 22 (11): 1882-1886. https://doi.org/10.2337/diacare.22.11.1882

  4. Kasuga, A

    1. Diet therapy improved ketosis without insulin therapy in a case of anti-GAD65+ diabetes.
      R Suzuki, A Shimada, A Kasuga and T Saruta
      Diabetes Care 1999 Nov; 22 (11): 1910-1911. https://doi.org/10.2337/diacare.22.11.1910

  5. Katoh, J

    1. Fasting serum insulin concentrations are associated with QTc duration independent of serum leptin, percent body fat, and BMI.
      T Kazumi, A Kawaguchi, J Katoh, Y Ikeda, K Kishi and G Yoshino
      Diabetes Care 1999 Nov; 22 (11): 1917-1918. https://doi.org/10.2337/diacare.22.11.1917

  6. Kawagishi, T

    1. Correlation between the intima-media thickness of the carotid artery and aortic pulse-wave velocity in patients with type 2 diabetes. Vessel wall properties in type 2 diabetes.
      H Taniwaki, T Kawagishi, M Emoto, T Shoji, H Kanda, K Maekawa, Y Nishizawa and H Morii
      Diabetes Care 1999 Nov; 22 (11): 1851-1857. https://doi.org/10.2337/diacare.22.11.1851
    2. Association of ACE gene polymorphism with arterial stiffness in patients with type 2 diabetes.
      H Taniwaki, T Kawagishi, M Emoto, T Shoji, M Hosoi, K Kogawa, Y Nishizawa and H Morii
      Diabetes Care 1999 Nov; 22 (11): 1858-1864. https://doi.org/10.2337/diacare.22.11.1858

  7. Kawaguchi, A

    1. Fasting serum insulin concentrations are associated with QTc duration independent of serum leptin, percent body fat, and BMI.
      T Kazumi, A Kawaguchi, J Katoh, Y Ikeda, K Kishi and G Yoshino
      Diabetes Care 1999 Nov; 22 (11): 1917-1918. https://doi.org/10.2337/diacare.22.11.1917

  8. Kazumi, T

    1. Fasting serum insulin concentrations are associated with QTc duration independent of serum leptin, percent body fat, and BMI.
      T Kazumi, A Kawaguchi, J Katoh, Y Ikeda, K Kishi and G Yoshino
      Diabetes Care 1999 Nov; 22 (11): 1917-1918. https://doi.org/10.2337/diacare.22.11.1917

  9. Khardori, R

    1. Lispro in the treatment of insulin allergy.
      M R Abraham, B A al-Sharafi, G A Saavedra and R Khardori
      Diabetes Care 1999 Nov; 22 (11): 1916-1917. https://doi.org/10.2337/diacare.22.11.1916

  10. Kiess, W

    1. Physical activity and competitive sports in children and adolescents with type 1 diabetes.
      K Raile, T Kapellen, A Schweiger, F Hunkert, U Nietzschmann, A Dost and W Kiess
      Diabetes Care 1999 Nov; 22 (11): 1904-1905. https://doi.org/10.2337/diacare.22.11.1904

  11. Kishi, K

    1. Fasting serum insulin concentrations are associated with QTc duration independent of serum leptin, percent body fat, and BMI.
      T Kazumi, A Kawaguchi, J Katoh, Y Ikeda, K Kishi and G Yoshino
      Diabetes Care 1999 Nov; 22 (11): 1917-1918. https://doi.org/10.2337/diacare.22.11.1917

  12. Kjekshus, J

    1. Effect of simvastatin treatment on cardiovascular resource utilization in impaired fasting glucose and diabetes. Findings from the Scandinavian Simvastatin Survival Study.
      W H Herman, C M Alexander, J R Cook, S J Boccuzzi, T A Musliner, T R Pedersen, J Kjekshus and K Pyörälä
      Diabetes Care 1999 Nov; 22 (11): 1771-1778. https://doi.org/10.2337/diacare.22.11.1771

  13. Ko, G T

    1. Use of a paired value of fasting plasma glucose and glycated hemoglobin in predicting the likelihood of diabetes in a community.
      G T Ko, J C Chan and C S Cockram
      Diabetes Care 1999 Nov; 22 (11): 1908-1909. https://doi.org/10.2337/diacare.22.11.1908

  14. Kogawa, K

    1. Association of ACE gene polymorphism with arterial stiffness in patients with type 2 diabetes.
      H Taniwaki, T Kawagishi, M Emoto, T Shoji, M Hosoi, K Kogawa, Y Nishizawa and H Morii
      Diabetes Care 1999 Nov; 22 (11): 1858-1864. https://doi.org/10.2337/diacare.22.11.1858

  15. Kromhout, D

    1. Diabetes prevalence in offspring of elderly men with known and newly diagnosed diabetes.
      E J Feskens, J M Boer, R M van Dam, M J Ritsema and D Kromhout
      Diabetes Care 1999 Nov; 22 (11): 1919. https://doi.org/10.2337/diacare.22.11.1919b

  16. Krüger, O

    1. Rapid changes in the prevalence of obesity and known diabetes in an adult Norwegian population. The Nord-Trøndelag Health Surveys: 1984-1986 and 1995-1997.
      K Midthjell, O Krüger, J Holmen, A Tverdal, T Claudi, A Bjørndal and P Magnus
      Diabetes Care 1999 Nov; 22 (11): 1813-1820. https://doi.org/10.2337/diacare.22.11.1813

L

  1. Lario, S

    1. Smoking increases serum levels of transforming growth factor-beta in diabetic patients.
      E Esmatjes, L Flores, S Lario, J Clària, A Cases, P Iñigo and J M Campistol
      Diabetes Care 1999 Nov; 22 (11): 1915-1916. https://doi.org/10.2337/diacare.22.11.1915

  2. Lebrethon, M C

    1. Cardiac autonomic dysfunction in diabetic children.
      M M Massin, B Derkenne, M Tallsund, D Rocour-Brumioul, C Ernould, M C Lebrethon and J P Bourguignon
      Diabetes Care 1999 Nov; 22 (11): 1845-1850. https://doi.org/10.2337/diacare.22.11.1845

  3. Lee, E T

    1. Glycemic control in diabetic American Indians. Longitudinal data from the Strong Heart Study.
      D Hu, J A Henderson, T K Welty, E T Lee, K A Jablonski, M F Magee, D C Robbins and B V Howard
      Diabetes Care 1999 Nov; 22 (11): 1802-1807. https://doi.org/10.2337/diacare.22.11.1802

  4. Lee, R H

    1. Insulin resistance. Does it play a role in peripheral neuropathy?
      R H Lee and A L Dellon
      Diabetes Care 1999 Nov; 22 (11): 1914-1915. https://doi.org/10.2337/diacare.22.11.1914

  5. Leonetti, D L

    1. Visceral adiposity and incident coronary heart disease in Japanese-American men. The 10-year follow-up results of the Seattle Japanese-American Community Diabetes Study.
      W Y Fujimoto, R W Bergstrom, E J Boyko, K W Chen, D L Leonetti, L Newell-Morris, J B Shofer and P W Wahl
      Diabetes Care 1999 Nov; 22 (11): 1808-1812. https://doi.org/10.2337/diacare.22.11.1808

  6. Lev-Ran, A

    1. Spontaneous recovery of severe weight loss in diabetic amyotrophy.
      A Lev-Ran and L Raskin
      Diabetes Care 1999 Nov; 22 (11): 1906-1907. https://doi.org/10.2337/diacare.22.11.1906

  7. Levetan, C S

    1. Effect of physician specialty on outcomes in diabetic ketoacidosis.
      C S Levetan, M D Passaro, K A Jablonski and R E Ratner
      Diabetes Care 1999 Nov; 22 (11): 1790-1795. https://doi.org/10.2337/diacare.22.11.1790

  8. Levina, E V

    1. Immediate feedback of HbA1c levels improves glycemic control in type 1 and insulin-treated type 2 diabetic patients.
      E Cagliero, E V Levina and D M Nathan
      Diabetes Care 1999 Nov; 22 (11): 1785-1789. https://doi.org/10.2337/diacare.22.11.1785

  9. Lim, S C

    1. Soluble intercellular adhesion molecule, vascular cell adhesion molecule, and impaired microvascular reactivity are early markers of vasculopathy in type 2 diabetic individuals without microalbuminuria.
      S C Lim, A E Caballero, P Smakowski, F W LoGerfo, E S Horton and A Veves
      Diabetes Care 1999 Nov; 22 (11): 1865-1870. https://doi.org/10.2337/diacare.22.11.1865

  10. Lipp, R W

    1. Is gastroparesis in diabetes cured by gastrectomy?
      W J Schnedl, H H Wenzl, B Obermayer-Pietsch, R E Roller and R W Lipp
      Diabetes Care 1999 Nov; 22 (11): 1920-1921. https://doi.org/10.2337/diacare.22.11.1920

  11. LoGerfo, F W

    1. Soluble intercellular adhesion molecule, vascular cell adhesion molecule, and impaired microvascular reactivity are early markers of vasculopathy in type 2 diabetic individuals without microalbuminuria.
      S C Lim, A E Caballero, P Smakowski, F W LoGerfo, E S Horton and A Veves
      Diabetes Care 1999 Nov; 22 (11): 1865-1870. https://doi.org/10.2337/diacare.22.11.1865

M

  1. Maekawa, K

    1. Correlation between the intima-media thickness of the carotid artery and aortic pulse-wave velocity in patients with type 2 diabetes. Vessel wall properties in type 2 diabetes.
      H Taniwaki, T Kawagishi, M Emoto, T Shoji, H Kanda, K Maekawa, Y Nishizawa and H Morii
      Diabetes Care 1999 Nov; 22 (11): 1851-1857. https://doi.org/10.2337/diacare.22.11.1851

  2. Magee, M F

    1. Glycemic control in diabetic American Indians. Longitudinal data from the Strong Heart Study.
      D Hu, J A Henderson, T K Welty, E T Lee, K A Jablonski, M F Magee, D C Robbins and B V Howard
      Diabetes Care 1999 Nov; 22 (11): 1802-1807. https://doi.org/10.2337/diacare.22.11.1802

  3. Magnus, P

    1. Rapid changes in the prevalence of obesity and known diabetes in an adult Norwegian population. The Nord-Trøndelag Health Surveys: 1984-1986 and 1995-1997.
      K Midthjell, O Krüger, J Holmen, A Tverdal, T Claudi, A Bjørndal and P Magnus
      Diabetes Care 1999 Nov; 22 (11): 1813-1820. https://doi.org/10.2337/diacare.22.11.1813

  4. Malik, R A

    1. Specific fiber deficits in sensorimotor diabetic polyneuropathy correspond to cytotoxicity against neuroblastoma cells of sera from patients with diabetes.
      G L Pittenger, R A Malik, N Burcus, A J Boulton and A I Vinik
      Diabetes Care 1999 Nov; 22 (11): 1839-1844. https://doi.org/10.2337/diacare.22.11.1839

  5. Malmberg, K

    1. Admission plasma glucose. Independent risk factor for long-term prognosis after myocardial infarction even in nondiabetic patients.
      A M Norhammar, L Rydén and K Malmberg
      Diabetes Care 1999 Nov; 22 (11): 1827-1831. https://doi.org/10.2337/diacare.22.11.1827

  6. Massin, M M

    1. Cardiac autonomic dysfunction in diabetic children.
      M M Massin, B Derkenne, M Tallsund, D Rocour-Brumioul, C Ernould, M C Lebrethon and J P Bourguignon
      Diabetes Care 1999 Nov; 22 (11): 1845-1850. https://doi.org/10.2337/diacare.22.11.1845

  7. McDonnell, M E

    1. Cutting the Gordian knot. Addition of metformin to insulin therapy in a patient with uncontrolled diabetes and schizophrenia.
      M E McDonnell and N B Ruderman
      Diabetes Care 1999 Nov; 22 (11): 1912-1913. https://doi.org/10.2337/diacare.22.11.1912

  8. Midthjell, K

    1. Rapid changes in the prevalence of obesity and known diabetes in an adult Norwegian population. The Nord-Trøndelag Health Surveys: 1984-1986 and 1995-1997.
      K Midthjell, O Krüger, J Holmen, A Tverdal, T Claudi, A Bjørndal and P Magnus
      Diabetes Care 1999 Nov; 22 (11): 1813-1820. https://doi.org/10.2337/diacare.22.11.1813

  9. Morii, H

    1. Correlation between the intima-media thickness of the carotid artery and aortic pulse-wave velocity in patients with type 2 diabetes. Vessel wall properties in type 2 diabetes.
      H Taniwaki, T Kawagishi, M Emoto, T Shoji, H Kanda, K Maekawa, Y Nishizawa and H Morii
      Diabetes Care 1999 Nov; 22 (11): 1851-1857. https://doi.org/10.2337/diacare.22.11.1851
    2. Association of ACE gene polymorphism with arterial stiffness in patients with type 2 diabetes.
      H Taniwaki, T Kawagishi, M Emoto, T Shoji, M Hosoi, K Kogawa, Y Nishizawa and H Morii
      Diabetes Care 1999 Nov; 22 (11): 1858-1864. https://doi.org/10.2337/diacare.22.11.1858

  10. Muggeo, M

    1. Chronic cigarette smoking is associated with increased plasma circulating intercellular adhesion molecule 1 levels in young type 1 diabetic patients.
      G Zoppini, G Targher, V Cacciatori, A Guerriero and M Muggeo
      Diabetes Care 1999 Nov; 22 (11): 1871-1874. https://doi.org/10.2337/diacare.22.11.1871

  11. Musliner, T A

    1. Effect of simvastatin treatment on cardiovascular resource utilization in impaired fasting glucose and diabetes. Findings from the Scandinavian Simvastatin Survival Study.
      W H Herman, C M Alexander, J R Cook, S J Boccuzzi, T A Musliner, T R Pedersen, J Kjekshus and K Pyörälä
      Diabetes Care 1999 Nov; 22 (11): 1771-1778. https://doi.org/10.2337/diacare.22.11.1771

N

  1. Nagasaka, S

    1. Homeostasis model assessment as a clinical index of insulin resistance. Comparison with the minimal model analysis.
      M Fukushima, A Taniguchi, M Sakai, K Doi, S Nagasaka, H Tanaka, K Tokuyama and Y Nakai
      Diabetes Care 1999 Nov; 22 (11): 1911-1912. https://doi.org/10.2337/diacare.22.11.1911

  2. Nakai, Y

    1. Homeostasis model assessment as a clinical index of insulin resistance. Comparison with the minimal model analysis.
      M Fukushima, A Taniguchi, M Sakai, K Doi, S Nagasaka, H Tanaka, K Tokuyama and Y Nakai
      Diabetes Care 1999 Nov; 22 (11): 1911-1912. https://doi.org/10.2337/diacare.22.11.1911

  3. Narayan, K M

    1. Reducing cardiovascular complications of type 2 diabetes. A complex but achievable and affordable task.
      P J Savage and K M Narayan
      Diabetes Care 1999 Nov; 22 (11): 1769-1770. https://doi.org/10.2337/diacare.22.11.1769

  4. Nathan, D M

    1. Immediate feedback of HbA1c levels improves glycemic control in type 1 and insulin-treated type 2 diabetic patients.
      E Cagliero, E V Levina and D M Nathan
      Diabetes Care 1999 Nov; 22 (11): 1785-1789. https://doi.org/10.2337/diacare.22.11.1785

  5. Newell-Morris, L

    1. Visceral adiposity and incident coronary heart disease in Japanese-American men. The 10-year follow-up results of the Seattle Japanese-American Community Diabetes Study.
      W Y Fujimoto, R W Bergstrom, E J Boyko, K W Chen, D L Leonetti, L Newell-Morris, J B Shofer and P W Wahl
      Diabetes Care 1999 Nov; 22 (11): 1808-1812. https://doi.org/10.2337/diacare.22.11.1808

  6. Nietzschmann, U

    1. Physical activity and competitive sports in children and adolescents with type 1 diabetes.
      K Raile, T Kapellen, A Schweiger, F Hunkert, U Nietzschmann, A Dost and W Kiess
      Diabetes Care 1999 Nov; 22 (11): 1904-1905. https://doi.org/10.2337/diacare.22.11.1904

  7. Nishizawa, Y

    1. Correlation between the intima-media thickness of the carotid artery and aortic pulse-wave velocity in patients with type 2 diabetes. Vessel wall properties in type 2 diabetes.
      H Taniwaki, T Kawagishi, M Emoto, T Shoji, H Kanda, K Maekawa, Y Nishizawa and H Morii
      Diabetes Care 1999 Nov; 22 (11): 1851-1857. https://doi.org/10.2337/diacare.22.11.1851
    2. Association of ACE gene polymorphism with arterial stiffness in patients with type 2 diabetes.
      H Taniwaki, T Kawagishi, M Emoto, T Shoji, M Hosoi, K Kogawa, Y Nishizawa and H Morii
      Diabetes Care 1999 Nov; 22 (11): 1858-1864. https://doi.org/10.2337/diacare.22.11.1858

  8. Nissinen, A

    1. Smoking and the risk of diabetes in elderly Finnish men. Retrospective analysis of data from a 30-year follow-up study.
      Q Qiao, T Valle, A Nissinen and J Tuomilehto
      Diabetes Care 1999 Nov; 22 (11): 1821-1826. https://doi.org/10.2337/diacare.22.11.1821

  9. Norhammar, A M

    1. Admission plasma glucose. Independent risk factor for long-term prognosis after myocardial infarction even in nondiabetic patients.
      A M Norhammar, L Rydén and K Malmberg
      Diabetes Care 1999 Nov; 22 (11): 1827-1831. https://doi.org/10.2337/diacare.22.11.1827

O

  1. Obermayer-Pietsch, B

    1. Is gastroparesis in diabetes cured by gastrectomy?
      W J Schnedl, H H Wenzl, B Obermayer-Pietsch, R E Roller and R W Lipp
      Diabetes Care 1999 Nov; 22 (11): 1920-1921. https://doi.org/10.2337/diacare.22.11.1920

  2. Oesterle, A

    1. Continuous subcutaneous insulin infusion. A new way to lower risk of severe hypoglycemia, improve metabolic control, and enhance coping in adolescents with type 1 diabetes.
      E A Boland, M Grey, A Oesterle, L Fredrickson and W V Tamborlane
      Diabetes Care 1999 Nov; 22 (11): 1779-1784. https://doi.org/10.2337/diacare.22.11.1779

P

  1. Passaro, M D

    1. Effect of physician specialty on outcomes in diabetic ketoacidosis.
      C S Levetan, M D Passaro, K A Jablonski and R E Ratner
      Diabetes Care 1999 Nov; 22 (11): 1790-1795. https://doi.org/10.2337/diacare.22.11.1790

  2. Pedersen, T R

    1. Effect of simvastatin treatment on cardiovascular resource utilization in impaired fasting glucose and diabetes. Findings from the Scandinavian Simvastatin Survival Study.
      W H Herman, C M Alexander, J R Cook, S J Boccuzzi, T A Musliner, T R Pedersen, J Kjekshus and K Pyörälä
      Diabetes Care 1999 Nov; 22 (11): 1771-1778. https://doi.org/10.2337/diacare.22.11.1771

  3. Perlmuter, L C

    1. Considering psychosocial variables in evaluating assessments of glycemic control.
      L C Perlmuter
      Diabetes Care 1999 Nov; 22 (11): 1918-1919. https://doi.org/10.2337/diacare.22.11.1918

  4. Perry, I J

    1. Impaired fasting glucose and cardiovascular disease.
      I J Perry
      Diabetes Care 1999 Nov; 22 (11): 1919-1920. https://doi.org/10.2337/diacare.22.11.1919a

  5. Pittenger, G L

    1. Specific fiber deficits in sensorimotor diabetic polyneuropathy correspond to cytotoxicity against neuroblastoma cells of sera from patients with diabetes.
      G L Pittenger, R A Malik, N Burcus, A J Boulton and A I Vinik
      Diabetes Care 1999 Nov; 22 (11): 1839-1844. https://doi.org/10.2337/diacare.22.11.1839

  6. Poehlman, E T

    1. Sex hormone-binding globulin levels in middle-aged premenopausal women. Associations with visceral obesity and metabolic profile.
      A Tchernof, M J Toth and E T Poehlman
      Diabetes Care 1999 Nov; 22 (11): 1875-1881. https://doi.org/10.2337/diacare.22.11.1875

  7. Pyörälä, K

    1. Effect of simvastatin treatment on cardiovascular resource utilization in impaired fasting glucose and diabetes. Findings from the Scandinavian Simvastatin Survival Study.
      W H Herman, C M Alexander, J R Cook, S J Boccuzzi, T A Musliner, T R Pedersen, J Kjekshus and K Pyörälä
      Diabetes Care 1999 Nov; 22 (11): 1771-1778. https://doi.org/10.2337/diacare.22.11.1771

Q

  1. Qiao, Q

    1. Smoking and the risk of diabetes in elderly Finnish men. Retrospective analysis of data from a 30-year follow-up study.
      Q Qiao, T Valle, A Nissinen and J Tuomilehto
      Diabetes Care 1999 Nov; 22 (11): 1821-1826. https://doi.org/10.2337/diacare.22.11.1821

R

  1. Raile, K

    1. Physical activity and competitive sports in children and adolescents with type 1 diabetes.
      K Raile, T Kapellen, A Schweiger, F Hunkert, U Nietzschmann, A Dost and W Kiess
      Diabetes Care 1999 Nov; 22 (11): 1904-1905. https://doi.org/10.2337/diacare.22.11.1904

  2. Ramíez Barba, E J

    1. Diabetic retinopathy and risk of blindness in Mexico. Are we doing enough?
      E Rodríguez Villalobos, E J Ramíez Barba, F C Cervantes Aguayo and E Vargas Salado
      Diabetes Care 1999 Nov; 22 (11): 1905. https://doi.org/10.2337/diacare.22.11.1905

  3. Raskin, L

    1. Spontaneous recovery of severe weight loss in diabetic amyotrophy.
      A Lev-Ran and L Raskin
      Diabetes Care 1999 Nov; 22 (11): 1906-1907. https://doi.org/10.2337/diacare.22.11.1906

  4. Ratner, R E

    1. Effect of physician specialty on outcomes in diabetic ketoacidosis.
      C S Levetan, M D Passaro, K A Jablonski and R E Ratner
      Diabetes Care 1999 Nov; 22 (11): 1790-1795. https://doi.org/10.2337/diacare.22.11.1790

  5. Ritsema, M J

    1. Diabetes prevalence in offspring of elderly men with known and newly diagnosed diabetes.
      E J Feskens, J M Boer, R M van Dam, M J Ritsema and D Kromhout
      Diabetes Care 1999 Nov; 22 (11): 1919. https://doi.org/10.2337/diacare.22.11.1919b

  6. Robbins, D C

    1. Glycemic control in diabetic American Indians. Longitudinal data from the Strong Heart Study.
      D Hu, J A Henderson, T K Welty, E T Lee, K A Jablonski, M F Magee, D C Robbins and B V Howard
      Diabetes Care 1999 Nov; 22 (11): 1802-1807. https://doi.org/10.2337/diacare.22.11.1802

  7. Rocour-Brumioul, D

    1. Cardiac autonomic dysfunction in diabetic children.
      M M Massin, B Derkenne, M Tallsund, D Rocour-Brumioul, C Ernould, M C Lebrethon and J P Bourguignon
      Diabetes Care 1999 Nov; 22 (11): 1845-1850. https://doi.org/10.2337/diacare.22.11.1845

  8. Rodríguez Villalobos, E

    1. Diabetic retinopathy and risk of blindness in Mexico. Are we doing enough?
      E Rodríguez Villalobos, E J Ramíez Barba, F C Cervantes Aguayo and E Vargas Salado
      Diabetes Care 1999 Nov; 22 (11): 1905. https://doi.org/10.2337/diacare.22.11.1905

  9. Roller, R E

    1. Is gastroparesis in diabetes cured by gastrectomy?
      W J Schnedl, H H Wenzl, B Obermayer-Pietsch, R E Roller and R W Lipp
      Diabetes Care 1999 Nov; 22 (11): 1920-1921. https://doi.org/10.2337/diacare.22.11.1920

  10. Ruderman, N B

    1. Cutting the Gordian knot. Addition of metformin to insulin therapy in a patient with uncontrolled diabetes and schizophrenia.
      M E McDonnell and N B Ruderman
      Diabetes Care 1999 Nov; 22 (11): 1912-1913. https://doi.org/10.2337/diacare.22.11.1912

  11. Rydén, L

    1. Admission plasma glucose. Independent risk factor for long-term prognosis after myocardial infarction even in nondiabetic patients.
      A M Norhammar, L Rydén and K Malmberg
      Diabetes Care 1999 Nov; 22 (11): 1827-1831. https://doi.org/10.2337/diacare.22.11.1827

S

  1. Saavedra, G A

    1. Lispro in the treatment of insulin allergy.
      M R Abraham, B A al-Sharafi, G A Saavedra and R Khardori
      Diabetes Care 1999 Nov; 22 (11): 1916-1917. https://doi.org/10.2337/diacare.22.11.1916

  2. Sakai, M

    1. Homeostasis model assessment as a clinical index of insulin resistance. Comparison with the minimal model analysis.
      M Fukushima, A Taniguchi, M Sakai, K Doi, S Nagasaka, H Tanaka, K Tokuyama and Y Nakai
      Diabetes Care 1999 Nov; 22 (11): 1911-1912. https://doi.org/10.2337/diacare.22.11.1911

  3. Saruta, T

    1. Diet therapy improved ketosis without insulin therapy in a case of anti-GAD65+ diabetes.
      R Suzuki, A Shimada, A Kasuga and T Saruta
      Diabetes Care 1999 Nov; 22 (11): 1910-1911. https://doi.org/10.2337/diacare.22.11.1910

  4. Savage, P J

    1. Reducing cardiovascular complications of type 2 diabetes. A complex but achievable and affordable task.
      P J Savage and K M Narayan
      Diabetes Care 1999 Nov; 22 (11): 1769-1770. https://doi.org/10.2337/diacare.22.11.1769

  5. Schnedl, W J

    1. Is gastroparesis in diabetes cured by gastrectomy?
      W J Schnedl, H H Wenzl, B Obermayer-Pietsch, R E Roller and R W Lipp
      Diabetes Care 1999 Nov; 22 (11): 1920-1921. https://doi.org/10.2337/diacare.22.11.1920

  6. Schnoell, F

    1. Prospective evaluation of urinary N-acetyl-beta-D-glucosaminidase with respect to macrovascular disease in elderly type 2 diabetic patients.
      R Weitgasser, F Schnoell, B Gappmayer and I Kartnig
      Diabetes Care 1999 Nov; 22 (11): 1882-1886. https://doi.org/10.2337/diacare.22.11.1882

  7. Schweiger, A

    1. Physical activity and competitive sports in children and adolescents with type 1 diabetes.
      K Raile, T Kapellen, A Schweiger, F Hunkert, U Nietzschmann, A Dost and W Kiess
      Diabetes Care 1999 Nov; 22 (11): 1904-1905. https://doi.org/10.2337/diacare.22.11.1904

  8. Shimada, A

    1. Diet therapy improved ketosis without insulin therapy in a case of anti-GAD65+ diabetes.
      R Suzuki, A Shimada, A Kasuga and T Saruta
      Diabetes Care 1999 Nov; 22 (11): 1910-1911. https://doi.org/10.2337/diacare.22.11.1910

  9. Shofer, J B

    1. Visceral adiposity and incident coronary heart disease in Japanese-American men. The 10-year follow-up results of the Seattle Japanese-American Community Diabetes Study.
      W Y Fujimoto, R W Bergstrom, E J Boyko, K W Chen, D L Leonetti, L Newell-Morris, J B Shofer and P W Wahl
      Diabetes Care 1999 Nov; 22 (11): 1808-1812. https://doi.org/10.2337/diacare.22.11.1808

  10. Shoji, T

    1. Correlation between the intima-media thickness of the carotid artery and aortic pulse-wave velocity in patients with type 2 diabetes. Vessel wall properties in type 2 diabetes.
      H Taniwaki, T Kawagishi, M Emoto, T Shoji, H Kanda, K Maekawa, Y Nishizawa and H Morii
      Diabetes Care 1999 Nov; 22 (11): 1851-1857. https://doi.org/10.2337/diacare.22.11.1851
    2. Association of ACE gene polymorphism with arterial stiffness in patients with type 2 diabetes.
      H Taniwaki, T Kawagishi, M Emoto, T Shoji, M Hosoi, K Kogawa, Y Nishizawa and H Morii
      Diabetes Care 1999 Nov; 22 (11): 1858-1864. https://doi.org/10.2337/diacare.22.11.1858

  11. Smakowski, P

    1. Soluble intercellular adhesion molecule, vascular cell adhesion molecule, and impaired microvascular reactivity are early markers of vasculopathy in type 2 diabetic individuals without microalbuminuria.
      S C Lim, A E Caballero, P Smakowski, F W LoGerfo, E S Horton and A Veves
      Diabetes Care 1999 Nov; 22 (11): 1865-1870. https://doi.org/10.2337/diacare.22.11.1865

  12. Smith, R L

    1. Painful peripheral diabetic neuropathy treated with venlafaxine HCl extended release capsules.
      J L Davis and R L Smith
      Diabetes Care 1999 Nov; 22 (11): 1909-1910. https://doi.org/10.2337/diacare.22.11.1909

  13. Steen-Müller, M K

    1. Type 2 diabetes and acute myocardial infarction. Angiographic findings and results of an invasive therapeutic approach in type 2 diabetic versus nondiabetic patients.
      B Waldecker, W Waas, W Haberbosch, R Voss, M K Steen-Müller, A Hiddessen, R Bretzel and H Tillmanns
      Diabetes Care 1999 Nov; 22 (11): 1832-1838. https://doi.org/10.2337/diacare.22.11.1832

  14. Sundkvist, G

    1. Obesity, microalbuminuria, hyperinsulinemia, and increased plasminogen activator inhibitor 1 activity associated with parasympathetic neuropathy in type 2 diabetes.
      B Szelag, M Wroblewski, J Castenfors, M Henricsson, K Berntorp, P Fernlund and G Sundkvist
      Diabetes Care 1999 Nov; 22 (11): 1907-1908. https://doi.org/10.2337/diacare.22.11.1907
    2. The relationship between leptin and the insulin resistance syndrome is disturbed in type 2 diabetic subjects with parasympathetic neuropathy.
      A Gottsäter, B Ahrén and G Sundkvist
      Diabetes Care 1999 Nov; 22 (11): 1913-1914. https://doi.org/10.2337/diacare.22.11.1913

  15. Suzuki, R

    1. Diet therapy improved ketosis without insulin therapy in a case of anti-GAD65+ diabetes.
      R Suzuki, A Shimada, A Kasuga and T Saruta
      Diabetes Care 1999 Nov; 22 (11): 1910-1911. https://doi.org/10.2337/diacare.22.11.1910

  16. Szelag, B

    1. Obesity, microalbuminuria, hyperinsulinemia, and increased plasminogen activator inhibitor 1 activity associated with parasympathetic neuropathy in type 2 diabetes.
      B Szelag, M Wroblewski, J Castenfors, M Henricsson, K Berntorp, P Fernlund and G Sundkvist
      Diabetes Care 1999 Nov; 22 (11): 1907-1908. https://doi.org/10.2337/diacare.22.11.1907

T

  1. Tallsund, M

    1. Cardiac autonomic dysfunction in diabetic children.
      M M Massin, B Derkenne, M Tallsund, D Rocour-Brumioul, C Ernould, M C Lebrethon and J P Bourguignon
      Diabetes Care 1999 Nov; 22 (11): 1845-1850. https://doi.org/10.2337/diacare.22.11.1845

  2. Tamborlane, W V

    1. Continuous subcutaneous insulin infusion. A new way to lower risk of severe hypoglycemia, improve metabolic control, and enhance coping in adolescents with type 1 diabetes.
      E A Boland, M Grey, A Oesterle, L Fredrickson and W V Tamborlane
      Diabetes Care 1999 Nov; 22 (11): 1779-1784. https://doi.org/10.2337/diacare.22.11.1779

  3. Tanaka, H

    1. Homeostasis model assessment as a clinical index of insulin resistance. Comparison with the minimal model analysis.
      M Fukushima, A Taniguchi, M Sakai, K Doi, S Nagasaka, H Tanaka, K Tokuyama and Y Nakai
      Diabetes Care 1999 Nov; 22 (11): 1911-1912. https://doi.org/10.2337/diacare.22.11.1911

  4. Taniguchi, A

    1. Homeostasis model assessment as a clinical index of insulin resistance. Comparison with the minimal model analysis.
      M Fukushima, A Taniguchi, M Sakai, K Doi, S Nagasaka, H Tanaka, K Tokuyama and Y Nakai
      Diabetes Care 1999 Nov; 22 (11): 1911-1912. https://doi.org/10.2337/diacare.22.11.1911

  5. Taniwaki, H

    1. Correlation between the intima-media thickness of the carotid artery and aortic pulse-wave velocity in patients with type 2 diabetes. Vessel wall properties in type 2 diabetes.
      H Taniwaki, T Kawagishi, M Emoto, T Shoji, H Kanda, K Maekawa, Y Nishizawa and H Morii
      Diabetes Care 1999 Nov; 22 (11): 1851-1857. https://doi.org/10.2337/diacare.22.11.1851
    2. Association of ACE gene polymorphism with arterial stiffness in patients with type 2 diabetes.
      H Taniwaki, T Kawagishi, M Emoto, T Shoji, M Hosoi, K Kogawa, Y Nishizawa and H Morii
      Diabetes Care 1999 Nov; 22 (11): 1858-1864. https://doi.org/10.2337/diacare.22.11.1858

  6. Targher, G

    1. Chronic cigarette smoking is associated with increased plasma circulating intercellular adhesion molecule 1 levels in young type 1 diabetic patients.
      G Zoppini, G Targher, V Cacciatori, A Guerriero and M Muggeo
      Diabetes Care 1999 Nov; 22 (11): 1871-1874. https://doi.org/10.2337/diacare.22.11.1871

  7. Tchernof, A

    1. Sex hormone-binding globulin levels in middle-aged premenopausal women. Associations with visceral obesity and metabolic profile.
      A Tchernof, M J Toth and E T Poehlman
      Diabetes Care 1999 Nov; 22 (11): 1875-1881. https://doi.org/10.2337/diacare.22.11.1875

  8. Tibbs, T L

    1. Smoking and diabetes.
      D Haire-Joshu, R E Glasgow and T L Tibbs
      Diabetes Care 1999 Nov; 22 (11): 1887-1898. https://doi.org/10.2337/diacare.22.11.1887

  9. Tillmanns, H

    1. Type 2 diabetes and acute myocardial infarction. Angiographic findings and results of an invasive therapeutic approach in type 2 diabetic versus nondiabetic patients.
      B Waldecker, W Waas, W Haberbosch, R Voss, M K Steen-Müller, A Hiddessen, R Bretzel and H Tillmanns
      Diabetes Care 1999 Nov; 22 (11): 1832-1838. https://doi.org/10.2337/diacare.22.11.1832

  10. Tokuyama, K

    1. Homeostasis model assessment as a clinical index of insulin resistance. Comparison with the minimal model analysis.
      M Fukushima, A Taniguchi, M Sakai, K Doi, S Nagasaka, H Tanaka, K Tokuyama and Y Nakai
      Diabetes Care 1999 Nov; 22 (11): 1911-1912. https://doi.org/10.2337/diacare.22.11.1911

  11. Toth, M J

    1. Sex hormone-binding globulin levels in middle-aged premenopausal women. Associations with visceral obesity and metabolic profile.
      A Tchernof, M J Toth and E T Poehlman
      Diabetes Care 1999 Nov; 22 (11): 1875-1881. https://doi.org/10.2337/diacare.22.11.1875

  12. Tuomilehto, J

    1. Smoking and the risk of diabetes in elderly Finnish men. Retrospective analysis of data from a 30-year follow-up study.
      Q Qiao, T Valle, A Nissinen and J Tuomilehto
      Diabetes Care 1999 Nov; 22 (11): 1821-1826. https://doi.org/10.2337/diacare.22.11.1821

  13. Tverdal, A

    1. Rapid changes in the prevalence of obesity and known diabetes in an adult Norwegian population. The Nord-Trøndelag Health Surveys: 1984-1986 and 1995-1997.
      K Midthjell, O Krüger, J Holmen, A Tverdal, T Claudi, A Bjørndal and P Magnus
      Diabetes Care 1999 Nov; 22 (11): 1813-1820. https://doi.org/10.2337/diacare.22.11.1813

V

  1. Valle, T

    1. Smoking and the risk of diabetes in elderly Finnish men. Retrospective analysis of data from a 30-year follow-up study.
      Q Qiao, T Valle, A Nissinen and J Tuomilehto
      Diabetes Care 1999 Nov; 22 (11): 1821-1826. https://doi.org/10.2337/diacare.22.11.1821

  2. van Dam, R M

    1. Diabetes prevalence in offspring of elderly men with known and newly diagnosed diabetes.
      E J Feskens, J M Boer, R M van Dam, M J Ritsema and D Kromhout
      Diabetes Care 1999 Nov; 22 (11): 1919. https://doi.org/10.2337/diacare.22.11.1919b

  3. Vargas Salado, E

    1. Diabetic retinopathy and risk of blindness in Mexico. Are we doing enough?
      E Rodríguez Villalobos, E J Ramíez Barba, F C Cervantes Aguayo and E Vargas Salado
      Diabetes Care 1999 Nov; 22 (11): 1905. https://doi.org/10.2337/diacare.22.11.1905

  4. Veves, A

    1. Soluble intercellular adhesion molecule, vascular cell adhesion molecule, and impaired microvascular reactivity are early markers of vasculopathy in type 2 diabetic individuals without microalbuminuria.
      S C Lim, A E Caballero, P Smakowski, F W LoGerfo, E S Horton and A Veves
      Diabetes Care 1999 Nov; 22 (11): 1865-1870. https://doi.org/10.2337/diacare.22.11.1865

  5. Vinik, A I

    1. Specific fiber deficits in sensorimotor diabetic polyneuropathy correspond to cytotoxicity against neuroblastoma cells of sera from patients with diabetes.
      G L Pittenger, R A Malik, N Burcus, A J Boulton and A I Vinik
      Diabetes Care 1999 Nov; 22 (11): 1839-1844. https://doi.org/10.2337/diacare.22.11.1839

  6. Voss, R

    1. Type 2 diabetes and acute myocardial infarction. Angiographic findings and results of an invasive therapeutic approach in type 2 diabetic versus nondiabetic patients.
      B Waldecker, W Waas, W Haberbosch, R Voss, M K Steen-Müller, A Hiddessen, R Bretzel and H Tillmanns
      Diabetes Care 1999 Nov; 22 (11): 1832-1838. https://doi.org/10.2337/diacare.22.11.1832

W

  1. Waas, W

    1. Type 2 diabetes and acute myocardial infarction. Angiographic findings and results of an invasive therapeutic approach in type 2 diabetic versus nondiabetic patients.
      B Waldecker, W Waas, W Haberbosch, R Voss, M K Steen-Müller, A Hiddessen, R Bretzel and H Tillmanns
      Diabetes Care 1999 Nov; 22 (11): 1832-1838. https://doi.org/10.2337/diacare.22.11.1832

  2. Wahl, P W

    1. Visceral adiposity and incident coronary heart disease in Japanese-American men. The 10-year follow-up results of the Seattle Japanese-American Community Diabetes Study.
      W Y Fujimoto, R W Bergstrom, E J Boyko, K W Chen, D L Leonetti, L Newell-Morris, J B Shofer and P W Wahl
      Diabetes Care 1999 Nov; 22 (11): 1808-1812. https://doi.org/10.2337/diacare.22.11.1808

  3. Waldecker, B

    1. Type 2 diabetes and acute myocardial infarction. Angiographic findings and results of an invasive therapeutic approach in type 2 diabetic versus nondiabetic patients.
      B Waldecker, W Waas, W Haberbosch, R Voss, M K Steen-Müller, A Hiddessen, R Bretzel and H Tillmanns
      Diabetes Care 1999 Nov; 22 (11): 1832-1838. https://doi.org/10.2337/diacare.22.11.1832

  4. Weitgasser, R

    1. Prospective evaluation of urinary N-acetyl-beta-D-glucosaminidase with respect to macrovascular disease in elderly type 2 diabetic patients.
      R Weitgasser, F Schnoell, B Gappmayer and I Kartnig
      Diabetes Care 1999 Nov; 22 (11): 1882-1886. https://doi.org/10.2337/diacare.22.11.1882

  5. Welty, T K

    1. Glycemic control in diabetic American Indians. Longitudinal data from the Strong Heart Study.
      D Hu, J A Henderson, T K Welty, E T Lee, K A Jablonski, M F Magee, D C Robbins and B V Howard
      Diabetes Care 1999 Nov; 22 (11): 1802-1807. https://doi.org/10.2337/diacare.22.11.1802

  6. Wenzl, H H

    1. Is gastroparesis in diabetes cured by gastrectomy?
      W J Schnedl, H H Wenzl, B Obermayer-Pietsch, R E Roller and R W Lipp
      Diabetes Care 1999 Nov; 22 (11): 1920-1921. https://doi.org/10.2337/diacare.22.11.1920

  7. Williams, A J

    1. Optimized autoantibody-based risk assessment in family members. Implications for future intervention trials.
      P J Bingley, A J Williams and E A Gale
      Diabetes Care 1999 Nov; 22 (11): 1796-1801. https://doi.org/10.2337/diacare.22.11.1796

  8. Wolfsdorf, J I

    1. Improving diabetes control in adolescents.
      J I Wolfsdorf
      Diabetes Care 1999 Nov; 22 (11): 1767-1768. https://doi.org/10.2337/diacare.22.11.1767

  9. Wroblewski, M

    1. Obesity, microalbuminuria, hyperinsulinemia, and increased plasminogen activator inhibitor 1 activity associated with parasympathetic neuropathy in type 2 diabetes.
      B Szelag, M Wroblewski, J Castenfors, M Henricsson, K Berntorp, P Fernlund and G Sundkvist
      Diabetes Care 1999 Nov; 22 (11): 1907-1908. https://doi.org/10.2337/diacare.22.11.1907

Y

  1. Yoshino, G

    1. Fasting serum insulin concentrations are associated with QTc duration independent of serum leptin, percent body fat, and BMI.
      T Kazumi, A Kawaguchi, J Katoh, Y Ikeda, K Kishi and G Yoshino
      Diabetes Care 1999 Nov; 22 (11): 1917-1918. https://doi.org/10.2337/diacare.22.11.1917

Z

  1. Zoppini, G

    1. Chronic cigarette smoking is associated with increased plasma circulating intercellular adhesion molecule 1 levels in young type 1 diabetic patients.
      G Zoppini, G Targher, V Cacciatori, A Guerriero and M Muggeo
      Diabetes Care 1999 Nov; 22 (11): 1871-1874. https://doi.org/10.2337/diacare.22.11.1871
Back to top